Nitric oxide inhibits microvascular protein leakage induced by leukocyte adhesion-independent and adhesion-dependent inflammatory mediators

Microcirculation

Volumn 6, Issue 2, 1999, Pages 153-162

  Johnston, Brent ^a   Gaboury, Jeffrey P ^a   Suematsu, Makoto ^b   Kubes, Paul ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b KEIO UNIVERSITY   (Japan)

Author keywords

cGMP; Chemokine; Histamine; Intravital microscopy; Leukocyte adhesion; Mast cell; Nitric oxide; Rolling; Vascular permeability; Venule

Indexed keywords

8 BROMO CYCLIC GMP; 8-BROMOCYCLIC GMP; ALPHA CHEMOKINE; AUTACOID; CHEMOTACTIC FACTOR; CXCL1 PROTEIN, RAT; CYCLIC GMP; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT, RAT; CYTOKINE-INDUCED NEUTROPHIL CHEMOATTRACTANT, RAT; DRUG DERIVATIVE; GROWTH PROMOTOR; HISTAMINE; NITRIC OXIDE; NITROGEN OXIDE; PROTEIN; SIGNAL PEPTIDE; SPERMINE; SPERMINE NITRIC OXIDE COMPLEX;

ANIMAL; ARTICLE; CAPILLARY PERMEABILITY; CELL ADHESION; DRUG EFFECT; LEUKOCYTE; MALE; MAST CELL; METABOLISM; MICROCIRCULATION; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CAPILLARY PERMEABILITY; CELL ADHESION; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; CYCLIC GMP; GROWTH SUBSTANCES; HISTAMINE; INFLAMMATION MEDIATORS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKOCYTES; MALE; MAST CELLS; MICROCIRCULATION; NITRIC OXIDE; NITROGEN OXIDES; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SPERMINE;

EID: 0033142899     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1080/713773949     Document Type: Article

References (60)

1. Adams MR, Jessup W, Hailstones D, Celermajer DS. (1997). L-arginine reduces human monocyte adhesion to vascular endothelium and endothelial expression of cell adhesion molecules. Circulation 95:662-668.
2. Alam R, Forsythe P, Lett-Brown MA, Grant JA. (1992). Macrophage inflammatory protein-1 α is an activator of basophils and mast cells. J Exp Med 176: 781-786.
3. Alam R, Grant JA. (1995). The chemokines and the histamine releasing factors: Modulation of function of basophils, mast cells, and eosinophils. In: Human Basophils and Mast Cells: Biological Aspects. (G Marone, Ed.) S. Karger AG. Basel. 148-157.
4. Asako H, Kurose I, Wolf R, DeFrees S, Zheng Z, Phillips ML, Paulson JC, Granger DN. (1994). Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in posteapillary venules. J Clin Invest 93:1508-1515.
5. 2-integrin function by inhibiting membrane-associated cyclic GMP synthesis. J Cell Physiol 172:12-24.
6. Barman SA, Pauly JR, Isales CM. (1997). Canine pulmonary vasoreactivity to serotonin: Role of protein kinase C and tyrosine kinase. Am J Physiol 272: H740-H747.
7. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. (1994). Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368:850-853.
8. Cirino G, Cicala C, Bucci MR, Sorrentino L, Maraganore JM, Stone SR. (1996). Thrombin functions as an inflammatory mediator through activation of its receptor. J Exp Med 183:821-827.
9. Clancy R, Leszczynska J, Amin A, Levartovsky D, Abramson SB. (1995). Nitric oxide stimulates ADP ribosylation of actin in association with the inhibition of actin polymerization in human neutrophils. J Leukoc Biol 58:196-202.
10. Clancy RM, Leszczynska-Piziak J, Abramson SB. (1992). Nitric oxide, and endothelial cell relaxation factor, inhibits neutrophil superoxide production via a direct action on the NADPH oxidase. J Clin Invest 90:1116-1121.
11. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone Jr. MA, Shin WS, Liao JK. (1995). Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60-68.
12. Fox-Robichaud A, Payne D, Hasan SU, Ostrovsky L, Fairhead T, Reinhardt P. (1998). Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest 101: 2497-2505.
13. Fukuda S, Yasu T, Schmid-Schönbein GW. (1998). The regulation of leukocyte response to shear stress by nitric oxide via cyclic GMP. FASEB J 12:A2 (Abstr.)
14. Gaboury J, Woodman RC, Granger DN, Reinhardt P, Kubes P. (1993). Nitric oxide prevents leukocyte adherence: Role of superoxide. Am J Physiol 265:H862-H867.
15. Gaboury JP, Johnston B, Niu X-F, Kubes P. (1995). Mechanisms underlying acute mast cell-induced leukocyte rolling and adhesion in vivo. J Immunol 154: 804-813.
16. Gaboury JP, Nin X-F, Kubes P. (1996). Nitric oxide inhibits numerous features of mast cell-induced inflammation. Circulation 93:318-326.
17. Gauthier TW, Davenpeck KL, Lefer AM. (1994). Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol 267:G562-G568.
18. Harris JG, Flower RJ, Watanabe K, Tsurufuji S, Wolitzky BA, Perretti M. (1996). Relative contribution of the selectins in the neutrophil recruitment caused by the chemokine cytokine-induced neutrophil chemoattractant (CINC). Biochem Biophys Res Commun 221:692-696.
19. Hempel A, Noll T, Muhs A, Piper HM. (1996). Functional antagonism between cAMP and cGMP on permeability of coronary endothelial monolayers. Am J Physiol 270:H1264-H1271.
20. Horan KL, Adamski SW, Ayele W, Langone JJ, Grega GJ. (1986). Evidence that prolonged histamine suffusions produce transient increases in vascular permeability subsequent to the formation of venular macromolecular leakage sites. Proof of the Majno-Palade hypothesis. Am J Pathol 123:570-576.
21. House SD, Lipowsky HH. (1987). Leukocyteendothelium adhesion: Microhemodynamics in mesentery of the cat. Microvasc Res 34:363-379.
22. Hughes SR, Williams TJ, Brain SD. (1990). Evidence that endogenous nitric oxide modulates oedema formation induced by substance P. Eur J Pharmacol 191:481-484.
23. Ignarro LJ. (1989). Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 65:1-21.
24. Ikeda M, Ikeda U, Takahashi M, Shimada K, Minota S, Kano S. (1996). Nitric oxide inhibits intracellular adhesion molecule-1 expression in rat mesangial cells. J Am Soc Nephrol 7:2213-2218.
25. 2. Am J Physiol 256:H1012-H1022.
26. Johnston B, Burns AR, Kubcs P. (1998). A role for mast cells in the development of adjuvant-induced vasculitis and arthritis. Am J Pathol 152:555-563.
27. Johnston B, Kanwar S, Kubes P. (1996). Hydrogen peroxide induces leukocyte rolling: modulation by endogenous antioxidant mechanisms including NO. Am J Physiol 271:H614-H621.
28. Kavanagh BP, Mouchawar A, Goldsmith J, Pearl RG. (1994). Effects of inhaled NO and inhibition of endogenous NO synthesis in oxidant-induced acute lung injury. J Appl Physiol 76:1324-1329.
29. Kemeny L, Ruzicka T, Dobozy A, Michel G. (1994). Role of the interleukin-8 receptor in skin. Int Arch Allergy Immunol 104:317-322.
30. Kubes P, Gaboury J. (1996). Rapid mast cell activation causes polymorphonuclear leukocyte and independent permeability alterations in postcapillary venules. Am J Physiol 271:H2438-H2446.
31. Kubes P, Granger DN. (1992). Nitric oxide modulates microvascular permeability. Am J Physiol 262:H611-H615.
32. Kubes P, Kanwar S. (1994). Histamine induces leukocyte rolling in post-capillary venules: A P-selectin-mediated event. J Immunol 152:3570-3577.
33. Kubes P, Kurose I, Granger DN. (1994). NO donors prevent integrin-induced leukocyte adhesion, but not P-selectin-dependent rolling in postischemic venules. Am J Physiol 267:H931-H937.
34. Kubes P, Reinhardt PH, Payne D, Woodman RC. (1995). Excess nitric oxide does not cause cellular, vascular or mucosal dysfunction in the cat small intestine. Am J Physiol 269:G34-G41.
35. Kubes P, Suzuki M, Granger DN. (1990). Modulation of PAF-induced leukocyte adherence and increased microvascular permeability. Am J Physiol 259:G859-G864.
36. Kubes P, Suzuki M, Granger DN. (1991). Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651-4655.
37. Kurose I, Anderson DC, Miyasaka M, Tamatani T, Paulson JC, Todd RF, Rusche JR, Granger DN. (1994). Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ Res 74:336-343.
38. Kurose I, Kubes P, Wolf R, Anderson DC, Paulson J, Miyasaka M, and Granger DN. (1993). Inhibition of nitric oxide production: Mechanisms of vascular albumin leakage. Circ Res 73:164-171.
39. Kurose I, Wolf R, Grisham MB, Aw TY, Specian RD, Granger DN. (1995). Microvascular responses to inhibition of nitric oxide production: role of active oxidants. Circ Res 76:30-39.
40. Kurose I, Wolf R, Grishain MB, Granger DN. (1994). Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. Circ Res 74: 376-382.
41. Lagunoff D. (1972). Vital staining of mast cells with ruthenium red. J Histochem Cytochem 20:938-944.
42. Lynch JM, Ferro TJ, Blumenstock FA, Brockenauer AM, Malik AB. (1990). Increased endothelial albumin permeability mediated by protein kinase C activation. J Clin Invest 85:1991-1998.
43. Maragos CM, Morley D, Wink DA, Dunams TM, Saavedra JE, Hoffman A, Bove AA, Issac L, Hrabie JA, Keefer LK. (1991). Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem 34:3242-3247.
44. May GR, Crook P, Moore PK, Page CP. (1991). The role of nitric oxide as an endogenous regulator of platelet and neutrophil activation within the pulmonary circulation of the rabbit. Br J Pharmacol 102: 759-763.
45. Mayhan WG. (1992). Role of nitric oxide in modulating permeability of hamster check pouch in response to adenosine 5'-diphosphate and bradykinin. Inflammation 16:295-305.
46. Moilanen E, Vuorinen P, Kankaanranta H, Metsa-Ketela T, Vapaatalo H. (1993). Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br J Pharmacol 109:852-858.
47. Moro MA, Russel RJ, Cellek S, Lizasoain I, Su Y, Darley-Usmar VM, Radomski MW, Moneada S. (1996). cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci USA 93:1480-1485.
48. Murohara T, Scalia R, Lefer AM. (1996). Lysophosphatidleholine promotes P-selectin expression in platelets and endothelial cells. Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circ Res 78:780-789.
49. Murray MA, Heistad DD, Mayhan WG. (1991). Role of protein kinase C in bradykinin-induced increases in microvascular permeability. Circ Res 68:1340-1348.
50. Niu X-F, Ibbotson G, Kubes P. (1996). A balance between nitric oxide and oxidants regulates mast cell-dependent neutrophil-endothelial cell interactions. Circ Res 79:992-999.
51. Paul W, Douglas GJ, Lawrence L, Khawaja AM, Perez AC, Schachter M, Page CP. (1994). Cutaneous permeability responses to bradykinin and histamine in the guinea-pig: possible differences in their mechanism of action. Br J Pharmacol 111:159-164.
52. Poss WB, Tirnmons OD, Farrukh IS, Hoidal JR, Michael JR. (1995). Inhaled nitric oxide prevents the increase in pulmonary vascular permeability increases caused by hydrogen peroxide. J Appl Physiol 79:886-891.
53. Spiecker M, Darius H, Kaboth K, Hubner F, Liao JK. (1998). Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukoc Biol 63:732-739.
54. Suematsu M, Tamatani T, Delano FA, Miyasaka M, Forrest M, Suzuki H, Schmid-Schönbein GW. (1994). Microvascular oxidative stress preceding leukocyte activation elicited by in vivo nitric oxide suppression. Am J Physiol 266:H2410-H2415.
55. Suzuki H, Suematsu M, Miura S, Liu YY, Watanabe K, Miyasaka M, Tsurufuji S, Tsuchiya M. (1994). Rat CINC/gro: A novel mediator for locomotive and secretagogue activation of neutrophils in vivo. J Leukoc Biol 55:652-657.
56. Wedmore CV and Williams TJ. (1981). Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature 289:646-650.
57. Wink'DA, Hanbauer I, Krishna MC, DeGraff W, Gamson J, Mitchell JB. (1993). Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci USA 90: 9813-9817.
58. Wu NZ, Baldwin AL. (1992). Transient venular permeability increase and endothelial gap formation induced by histamine. Am J Physiol 262:H1238-H1247.
59. Yano H, Wershil BK, Arizono N, Galli SJ. (1989). Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent. J Clin Invest 84:1276-1286.
60. Yuan Y, Granger HJ, Zawieja DC, DeFily DV, Chilian WM. (1993). Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. Am J Physiol 264:H1734-H1739.